CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

4.150

+0.180 (4.53%)

At close: Nov 25, 2025, 4:00 PM EST

4.240

+0.090 (2.17%)

Pre-market: Nov 26, 2025, 5:15 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
Probody Therapeutics	138.10M	Log In	Log In	Log In	Log In	Upgrade
Probody Therapeutics Growth	36.45%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
United States	138.10M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	36.45%	Log In	Log In	Log In	Log In	Upgrade